Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
Open Access
- 1 January 2012
- journal article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. 7, 369-379
- https://doi.org/10.2147/ijn.s27226
Abstract
Background: Hepatocellular carcinoma is difficult to diagnose early, and most patients are already in the late stages of the disease when they are admitted to hospital. The total 5-year survival rate is less than 5%. Recent studies have showed that brucine has a good anti-tumor effect, but high toxicity, poor water solubility, short half-life, narrow therapeutic window, and a toxic dose that is close to the therapeutic dose, which all limit its clinical application. This study evaluated the effects of brucine immuno-nanoparticles (BIN) on hepatocellular carcinoma. Materials and methods: Anionic polymerization, chemical modification technology, and phacoemulsification technology were used to prepare a carboxylated polyethylene glycol-polylactic acid copolymer carrier material. Chemical coupling technology was utilized to develop anti-human AFP McAb-polyethylene glycol-polylactic acid copolymer BIN. The size, shape, zeta potential, drug loading, encapsulation efficiency, and release of these immune-nanoparticles were studied in vitro. The targeting, and growth, invasion, and metastasis inhibitory effects of this treatment on liver cancer SMMC-7721 cells were tested. Results: BIN were of uniform size with an average particle size of 249 ± 77 nm and zeta potential of -18.7 ± 4.19 mV. The encapsulation efficiency was 76.0% ± 2.3% and the drug load was 5.6% ± 0.2%. Complete uptake and even distribution around the liver cancer cell membrane were observed. Conclusion: BIN had even size distribution, was stable, and had a slow-releasing effect. BIN targeted the cell membrane of the liver cancer cell SMMC-7721 and significantly inhibited the growth, adhesion, invasion, and metastasis of SMMC-7721 cells. As a novel drug carrier system, BIN are a potentially promising targeting treatment for liver cancer.Keywords
This publication has 25 references indexed in Scilit:
- Basement membrane components are key players in specialized extracellular matricesCellular and Molecular Life Sciences, 2010
- Clinical Significance of Elevated Alpha-Fetoprotein (AFP) in Patients with Chronic Hepatitis C, but not Hepatocellular CarcinomaThe American Journal of Gastroenterology, 2004
- A decade?s studies on metastasis of hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle CellsPharmaceutical Research, 2003
- Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJournal of Controlled Release, 2002
- Targeting hepatocytes for drug and gene delivery emerging novel approaches and applicationsFrontiers in Bioscience-Landmark, 2002
- Characterization of nanoparticle uptake by endothelial cellsInternational Journal of Pharmaceutics, 2001
- Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resectionJournal of the American College of Surgeons, 2000
- Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vesselClinical & Experimental Metastasis, 1996
- Liver transplantation for hepatocarcinomaSurgery Today, 1993